scispace - formally typeset
J

Julia Emerson

Researcher at University of Washington

Publications -  52
Citations -  7678

Julia Emerson is an academic researcher from University of Washington. The author has contributed to research in topics: Pseudomonas aeruginosa & Cystic fibrosis. The author has an hindex of 36, co-authored 52 publications receiving 7052 citations. Previous affiliations of Julia Emerson include University of North Carolina at Chapel Hill & Novartis.

Papers
More filters
Journal ArticleDOI

Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis.

TL;DR: A registry‐based study to determine prognostic indicators of 8‐year mortality and morbidity in young children with cystic fibrosis (CF) and clinical outcomes in 1998 is conducted.
Journal ArticleDOI

Longitudinal assessment of Pseudomonas aeruginosa in young children with cystic fibrosis.

TL;DR: Genotypic and phenotypic changes in P. aeruginosa from oropharynx and bronchoalveolar lavage fluid in a cohort of 40 CF patients during the first 3 years of life suggest infection occurs early in CF and may be intermittent or undetectable by culture.
Journal ArticleDOI

Microbiology of Sputum from Patients at Cystic Fibrosis Centers in the United States

TL;DR: Compared with the Cystic Fibrosis Foundation Patient Registry, the current study identified many more patients colonized with S. aureus, suggesting the utility of standardized processing of CF specimens.
Journal ArticleDOI

Selection for Staphylococcus aureus small-colony variants due to growth in the presence of Pseudomonas aeruginosa

TL;DR: In this paper, the authors show that suppression of S. aureus respiration by a 4-hydroxy-2-heptylquinoline-Noxide (HQNO) exoproduct, 4-H2HNoxide, protects Pseudomonas aeruginosa during coculture from killing by commonly used aminoglycoside antibiotics such as tobramycin.
Journal ArticleDOI

Early pulmonary infection, inflammation, and clinical outcomes in infants with cystic fibrosis.

TL;DR: The evolution of pulmonary infection, inflammation, and clinical course among 40 infants over a 2‐year period through annual bronchoalveolar lavage for culture and measurements of pro‐ and anti‐inflammatory cytokines and quarterly clinical evaluations is assessed.